Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung

7680690650018 CH-69065 Pulver
Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung
Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung
Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/02/2026
Summary of Product Characteristics
Français
04/02/2026
Summary of Product Characteristics
Italien
04/02/2026

Detailed composition

Substance Quantity Type Category
romiplostimum
125.0 UG Substance Wirkstoff (Principe actif)
mannitolum
- Substance HNIDK
saccharum
- Substance HNIDK
histidinum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
acidum hydrochloridum dilutum
- Substance HNIDK

Reimbursement information

Public price
CHF 259.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2024

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
69065
Drug name
Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
B02BX04
Authorization status
Z
Dispensing category
A
First authorization
06/06/2023
Authorization expiration date
05/06/2028
IT Number
06.99.0.
Domain
Human medicine
Field of application
Chronische (idiopathische) immunthrombozytopenische Purpura (ITP)

Package details

Description (FR)
NPLATE subst sèche 125 mcg flac
Description (DE)
NPLATE Trockensub 125 mcg Durchstf
Market launch
06/06/2023
Narcotic (BTM)
No
Buy us a coffee Explore the data